Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Tune Therapeutics Presents Positive Phase 1b/2a Proof of Concept Data on TUNE-401: a First-in-Class Epigenetic Silencer for Patients with Hepatitis B at EASL 2026

Summary by Hastings Tribune
DURHAM, N.C. & SEATTLE--(BUSINESS WIRE)--May 30, 2026-

3 Articles

Hastings TribuneHastings Tribune
+2 Reposted by 2 other sources
Center

Tune Therapeutics Presents Positive Phase 1b/2a Proof of Concept Data on TUNE-401: a First-in-Class Epigenetic Silencer for Patients with Hepatitis B at EASL 2026

DURHAM, N.C. & SEATTLE--(BUSINESS WIRE)--May 30, 2026-

·Nebraska, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Carroll County Mirror-Democrat broke the news in Mount Carroll, United States on Saturday, May 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Hepatitis B icon

Hepatitis B

Durham, North Carolina icon

Durham, North Carolina

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal